267 related articles for article (PubMed ID: 18925698)
1. Cyclin D1 and p27 expression as prognostic factor in papillary carcinoma of thyroid: association with clinicopathological parameters.
Pesutić-Pisac V; Punda A; Gluncić I; Bedeković V; Pranić-Kragić A; Kunac N
Croat Med J; 2008 Oct; 49(5):643-9. PubMed ID: 18925698
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1, Ret and P27 Expression in Papillary Thyroid Microcarcinoma.
Barić A; Marković V; Eterović D; Bedeković V; Kontić M; Juretić Kuščić L; Pešutić Pisac V; Punda A
Acta Clin Croat; 2017 Mar; 56(1):15-20. PubMed ID: 29120119
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma.
Khoo ML; Beasley NJ; Ezzat S; Freeman JL; Asa SL
J Clin Endocrinol Metab; 2002 Apr; 87(4):1814-8. PubMed ID: 11932323
[TBL] [Abstract][Full Text] [Related]
4. Papillary microcarcinomas of the thyroid with preoperatively detectable lymph node metastasis show significantly higher aggressive characteristics on immunohistochemical examination.
Ito Y; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
Oncology; 2005; 68(2-3):87-96. PubMed ID: 15886500
[TBL] [Abstract][Full Text] [Related]
5. BRAF V600E mutation and p27 kip1 expression in papillary carcinomas of the thyroid Rodolico V; Cabibi D; Pizzolanti G; Richiusa P; Gebbia N; Martorana A; Russo A; Amato MC; Galluzzo A; Giordano C
Cancer; 2007 Sep; 110(6):1218-26. PubMed ID: 17685465
[TBL] [Abstract][Full Text] [Related]
6. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma.
Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH
Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376
[TBL] [Abstract][Full Text] [Related]
7. Survivin and cyclin D1 are jointly expressed in thyroid papillary carcinoma and microcarcinoma.
Antonaci A; Consorti F; Mardente S; Natalizi S; Giovannone G; Della Rocca C
Oncol Rep; 2008 Jul; 20(1):63-7. PubMed ID: 18575719
[TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor beta receptors and p27kip in thyroid carcinoma.
Muro-Cacho CA; Muñoz-Antonia T; Livingston S; Klotch D
Arch Otolaryngol Head Neck Surg; 1999 Jan; 125(1):76-81. PubMed ID: 9932593
[TBL] [Abstract][Full Text] [Related]
9. Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma.
Jung CK; Kang YG; Bae JS; Lim DJ; Choi YJ; Lee KY
Mod Pathol; 2010 Sep; 23(9):1201-8. PubMed ID: 20543822
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential.
Lamba Saini M; Weynand B; Rahier J; Mourad M; Hamoir M; Marbaix E
Diagn Pathol; 2015 Apr; 10():32. PubMed ID: 25907675
[TBL] [Abstract][Full Text] [Related]
11. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome.
Sgambato A; Migaldi M; Faraglia B; De Aloysio G; Ferrari P; Ardito R; De Gaetani C; Capelli G; Cittadini A; Trentini GP
Int J Cancer; 2002 Feb; 97(5):671-8. PubMed ID: 11807796
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of cyclins and cell cycle inhibitors in papillary thyroid cancer: prognostic implications.
Pickett CA; Agoff SN; Widman TJ; Bronner MP
Thyroid; 2005 May; 15(5):461-73. PubMed ID: 15929668
[TBL] [Abstract][Full Text] [Related]
13. The role of cell cycle regulatory proteins, cyclin D1, cyclin E, and p27 in thyroid carcinogenesis.
Wang S; Wuu J; Savas L; Patwardhan N; Khan A
Hum Pathol; 1998 Nov; 29(11):1304-9. PubMed ID: 9824112
[TBL] [Abstract][Full Text] [Related]
14. Expression of proteins: D1 cyclin and Ki-67 in papillary thyroid carcinomas.
Timler D; Tazbir J; Matejkowska M; Gosek A; Czyz W; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():201-2. PubMed ID: 11820608
[TBL] [Abstract][Full Text] [Related]
15. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
17. Cell cycle regulators show diagnostic and prognostic utility for differentiated thyroid cancer.
Melck A; Masoudi H; Griffith OL; Rajput A; Wilkins G; Bugis S; Jones SJ; Wiseman SM
Ann Surg Oncol; 2007 Dec; 14(12):3403-11. PubMed ID: 17882495
[TBL] [Abstract][Full Text] [Related]
18. Clinical relevance of expression of the CIP/KIP cell-cycle inhibitors p21 and p27 in laryngeal cancer.
Pruneri G; Pignataro L; Carboni N; Buffa R; Di Finizio D; Cesana BM; Neri A
J Clin Oncol; 1999 Oct; 17(10):3150-9. PubMed ID: 10506612
[TBL] [Abstract][Full Text] [Related]
19. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
[TBL] [Abstract][Full Text] [Related]
20. Clinical value of Cyclin D1 and P21 in the differential diagnosis of papillary thyroid carcinoma.
Wang CC; Lu DD; Shen MH; Chen RL; Zhang ZH; Lv JH
Diagn Pathol; 2023 Nov; 18(1):123. PubMed ID: 37951919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
